Cliquez ici pour connaître notre offre FCPI

The fast pace of innovation in IT offers compelling investment opportunities

Truffle Capital is a pioneer investor in the exciting field of Energy

Biotechnology has radically transformed medicine over the past 25 years


  • “ Truffle Capital has been an industrial, strategic and financial partner to Vexim since the creation of the company in 2006 and has enabled Vexim to acquire an international role within the treatment of spine fractures. The partners of Truffle Capital are passionate entrepreneurs, keen on innovation and understand a company’s needs and its people. They have taken measured risks, helped Vexim in fulfilling its aims and accompanied us in our progress, for which we are very grateful.  ”Vexim
    Vincent Gardes / CEO

Truffle Capital is an independent European venture capital firm

Truffle Capital is an independent venture capital firm investing in Europe. Established in 2001 and with close to €700 million under management and advisory as of the 30th June 2014, Truffle Capital is an important and independent European private equity firm, specialized in investments in spin-offs from companies active in the Energy, Information Technology and Life Sciences sectors. The firm is led by a team of three General Partners with decades of successful investment and entrepreneurial experience in both Europe and in the USA.

Backed by an investment team of international experts and an experienced support team, a total of 16 professionals, Truffle Capital aims to achieve superior financial returns by leveraging its industry knowledge, extensive network, and operational experience to identify business opportunities that match latent market needs.


01-2015

DIETSWELL

26th January 2015 – 2014 Revenue: + 67% at 28.9 M€ (+ 76% on H2-2014)

Pdf


+ read more
01-2015

CARMAT

22nd January 2015 – CARMAT will benefit from the European SEED1 program that supports innovative therapy developers seeking reimbursement

Pdf


+ read more
01-2015

DENY-ALL

15th January 2015 – DenyAll streamlines its product line, is awarded ‘France Cybersecurity’ label

Pdf


+ read more
01-2015

DEINOVE

21st January 2015 – DEINOVE SUCCESSFULLY COMPLETES THE FIRST KEY MILESTONE OF ITS DEINOCHEM PROGRAM AND RECEIVES 1 MILLION EUROS

Pdf


+ read more